NLS Pharmaceutics Ltd. (NASDAQ:NLSP) Short Interest Down 28.2% in March

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) was the target of a large decrease in short interest in March. As of March 15th, there was short interest totalling 41,800 shares, a decrease of 28.2% from the February 28th total of 58,200 shares. Based on an average trading volume of 2,580,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 2.7% of the company’s stock are short sold.

NLS Pharmaceutics Stock Up 18.5 %

Shares of NLSP traded up $0.24 during midday trading on Monday, reaching $1.54. 122,240 shares of the stock were exchanged, compared to its average volume of 835,119. The business’s 50-day moving average price is $1.85 and its 200 day moving average price is $2.55. NLS Pharmaceutics has a twelve month low of $1.30 and a twelve month high of $18.39.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).